Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123700402 | 12370040 | 2 | F | 2009 | 20160818 | 20160516 | 20160825 | EXP | US-JAZZ-2016-US-008588 | JAZZ | 0.00 | M | Y | 0.00000 | 20160825 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123700402 | 12370040 | 1 | PS | XYREM | SODIUM OXYBATE | 1 | Oral | 2.25 G, BID | U | 21196 | 2.25 | G | ORAL SOLUTION | ||||||
| 123700402 | 12370040 | 2 | SS | XYREM | SODIUM OXYBATE | 1 | Oral | DOSE ADJUSTMENTS | U | 21196 | ORAL SOLUTION | ||||||||
| 123700402 | 12370040 | 3 | SS | XYREM | SODIUM OXYBATE | 1 | Oral | 4.5 G, BID | U | 21196 | 4.5 | G | ORAL SOLUTION | ||||||
| 123700402 | 12370040 | 4 | C | AMBIEN | ZOLPIDEM TARTRATE | 1 | U | 0 | |||||||||||
| 123700402 | 12370040 | 5 | C | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | U | 0 | |||||||||||
| 123700402 | 12370040 | 6 | C | GLUCOVANCE | GLYBURIDEMETFORMIN HYDROCHLORIDE | 1 | U | 0 | |||||||||||
| 123700402 | 12370040 | 7 | C | LASIX | FUROSEMIDE | 1 | U | 0 | |||||||||||
| 123700402 | 12370040 | 8 | C | LIPITOR | ATORVASTATIN CALCIUM | 1 | U | 0 | |||||||||||
| 123700402 | 12370040 | 9 | C | NEURONTIN | GABAPENTIN | 1 | U | 0 | |||||||||||
| 123700402 | 12370040 | 10 | C | VALIUM | DIAZEPAM | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123700402 | 12370040 | 1 | Narcolepsy |
| 123700402 | 12370040 | 4 | Product used for unknown indication |
| 123700402 | 12370040 | 5 | Product used for unknown indication |
| 123700402 | 12370040 | 6 | Product used for unknown indication |
| 123700402 | 12370040 | 7 | Product used for unknown indication |
| 123700402 | 12370040 | 8 | Product used for unknown indication |
| 123700402 | 12370040 | 9 | Product used for unknown indication |
| 123700402 | 12370040 | 10 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123700402 | 12370040 | OT |
| 123700402 | 12370040 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123700402 | 12370040 | Cardiac failure | |
| 123700402 | 12370040 | Influenza | |
| 123700402 | 12370040 | Pre-existing condition improved | |
| 123700402 | 12370040 | Therapeutic response unexpected |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123700402 | 12370040 | 1 | 200905 | 200908 | 0 | |
| 123700402 | 12370040 | 2 | 200908 | 201003 | 0 | |
| 123700402 | 12370040 | 3 | 201003 | 0 |